Fast Five Quiz: Systemic Treatments for Plaque Psoriasis

Chris G. Adigun, MD


May 21, 2020

The National Psoriasis Foundation recently defined acceptable response criteria as an achievement of BSA ≤ 3% or a BSA improvement of ≥ 75% from baseline, and noted the importance of establishing treatment goals to improve the care of patients with psoriasis.

Regardless of the type of therapy being initiated, psoriasis experts agree that a follow-up evaluation should be performed 3 months after treatment initiation to assess tolerability and clinical response. Regular follow-up evaluations should be performed every 6 months thereafter. Escalation to a biologic medication may be considered for patients who have an inadequate response to oral systemic agents at any point during the course of treatment.

For additional information, refer to the British Association of Dermatologists guidelines for biologic therapy for psoriasis and the Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with biologics.

Learn more about systemic and biologic treatments for plaque psoriasis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: